Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,129) with videos related to
Page
of 113
Sort By:
The Oncologist
|
July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Wael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 5, 2026
A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults
James J Kobie, Wilton B Williams, William O Hahn, et al.
The Journal of Infectious Diseases
|
January 12, 2018
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong, Xiaoying Shen, Vicki C Ashley, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 15, 2020
Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic Symposium
Lusine Ambartsumyan, Julie Khlevner, Samuel Nurko, et al.
The Journal of Experimental Medicine
|
September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
William O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
William O Hahn, K Rachael Parks, Mingchao Shen, et al.
Micropublication Biology
|
March 27, 2026
Complete Genome Sequence of the Subcluster C1 Mycobacteriophage LordLeafolot
Jenna Cagle, MacKenzie Kral, Lauryn Carrington, et al.
Emerging Microbes & Infections
|
April 7, 2025
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Zoe Moodie, Shuying Sue Li, Elena E Giorgi, et al.
The New England Journal of Medicine
|
September 29, 2021
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Ann R Falsey, Magdalena E Sobieszczyk, Ian Hirsch, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Page
of 113
Search research articles
Search
Showing results (1111-1120 of 1,129) with videos related to
Sort By:
Page
of 113
The Oncologist
|
July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing
Wael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 5, 2026
A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults
James J Kobie, Wilton B Williams, William O Hahn, et al.
The Journal of Infectious Diseases
|
January 12, 2018
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial
Youyi Fong, Xiaoying Shen, Vicki C Ashley, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
April 15, 2020
Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic Symposium
Lusine Ambartsumyan, Julie Khlevner, Samuel Nurko, et al.
The Journal of Experimental Medicine
|
September 5, 2024
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
William O Hahn, K Rachael Parks, Mingchao Shen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 20, 2024
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
William O Hahn, K Rachael Parks, Mingchao Shen, et al.
Micropublication Biology
|
March 27, 2026
Complete Genome Sequence of the Subcluster C1 Mycobacteriophage LordLeafolot
Jenna Cagle, MacKenzie Kral, Lauryn Carrington, et al.
Emerging Microbes & Infections
|
April 7, 2025
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Zoe Moodie, Shuying Sue Li, Elena E Giorgi, et al.
The New England Journal of Medicine
|
September 29, 2021
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
Ann R Falsey, Magdalena E Sobieszczyk, Ian Hirsch, et al.
The Lancet. Infectious Diseases
|
January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study
Saranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Page
of 113